AKT1 and cancer: Indeed, pharmacological inhibitors of Akt/mTOR signaling, through regulation of autophagy, have emerged as promising approaches for therapeutics against cancers or liver diseases (Wang et al., 2019; Kaleagasioglu et al., 2020).